Fulcrum Therapeutics share price today

(FULC)

Fulcrum Therapeutics share price is $4.55 & ₹387.65 as on 25 Dec 2024, 2.30 'hrs' IST

$4.55

▲

-0.13

(-2.78%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Fulcrum Therapeutics share price in Dollar and Rupees. Guide to invest in Fulcrum Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Fulcrum Therapeutics. Get details on the Indian mutual funds that are investing in Fulcrum Therapeutics. Get Analyst recommendations and forecasts along with all the Fulcrum Therapeutics's financials.

Fulcrum Therapeutics share price movements

Today's Low: $4.35
Today's High: $4.76
$4.55
4.4%
Downside
Day's Volatility :8.52%
Upside
4.31%
52 Weeks Low: $2.86
52 Weeks High: $13.70
$4.55
37.14%
Downside
52 Weeks Volatility :79.12%
Upside
66.79%

Fulcrum Therapeutics Returns

Period	Fulcrum Therapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	13.75%	-9.0%	0.0%
6 Months	-27.55%	-4.6%	0.0%
1 Year	-32.59%	3.0%	0.0%
3 Years	-74.24%	0.0%	-21.1%

Fulcrum Therapeutics Key Statistics

in dollars & INR

Previous Close	$4.68
Open	$4.7
Today's High	$4.755
Today's Low	$4.35
Market Capitalization	$245.4M
Today's Volume	$729.2K
52 Week High	$13.7
52 Week Low	$2.86
Revenue TTM	$81.6M
EBITDA	$-30.9M
Earnings Per Share (EPS)	$-0.29
Profit Margin	-24.79%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-7.37%

How to invest in Fulcrum Therapeutics from India?

It is very easy for Indian residents to invest directly in Fulcrum Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Fulcrum Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Fulcrum Therapeutics or FULC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Fulcrum Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Fulcrum Therapeutics shares which would translate to 0.187 fractional shares of Fulcrum Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Fulcrum Therapeutics, in just a few clicks!

Returns in Fulcrum Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Fulcrum Therapeutics investment value today

Current value as on today

₹69,646

Returns

₹30,354

(-30.35%)

Returns from Fulcrum Therapeutics Stock

₹32,593 (-32.59%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Fulcrum Therapeutics

-66%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Fulcrum Therapeutics on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -66% less investors are searching Fulcrum Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Fulcrum Therapeutics

RA Capital Management, LLC
18.96%
TCG Crossover Management, LLC
9.73%
BlackRock Inc
8.90%
Nantahala Capital Management, LLC
8.86%
Vanguard Group Inc
6.07%
TRV GP IV, LLC
4.34%

Analyst Recommendation on Fulcrum Therapeutics

Buy

78%Buy

14%Hold

7%Sell

Based on 14 Wall street analysts offering stock ratings for Fulcrum Therapeutics(by analysts ranked 0 to 5 stars)

Based on 14 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Fulcrum Therapeutics

What analysts predicted

Upside of 16.17%

Current:

$4.55

Target:

$5.29

Insights on Fulcrum Therapeutics

Price Movement
In the last 7 days, FULC stock has moved up by 12.9%
Increasing Revenue
Revenue is up for the last 3 quarters, 759.0K → 80.0M (in $), with an average increase of 55.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 55.40M → -21.69M (in $), with an average decrease of 139.2% per quarter
FULC vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 58.4%
FULC vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 100.1%
Price to Sales
ForFULC every $1 of sales, investors are willing to pay $3.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Fulcrum Therapeutics Technicals Summary

Sell

Neutral

Buy

Fulcrum Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Fulcrum Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Fulcrum Therapeutics Inc	28.17%	-27.55%	-32.59%	-74.24%	-73.93%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Fulcrum Therapeutics Inc	NA	NA	NA	-0.15	-0.07	-0.07	NA	3.8
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Fulcrum Therapeutics Inc	Buy	$245.4M	-73.93%	NA	-24.79%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Fulcrum Therapeutics

what if we could regulate genes, not just discover them? what if we could treat disease at their genetic source? what if we could integrate multiple disciplines to develop breakthrough medicines? what if you could be a part of a passionate team committed to the patients we serve? we can. we will. we are. join us. we are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. a fulcrum is defined as the point on which a lever rests, balances and pivots. fulcrum therapeutics is intervening in gene regulatory mechanisms to unlock the information contained in the human genome. the fulcrum product engine is dedicated to bringing balance to the genetic on and off switches in disease. our approach the sequencing of the human genome has provided incredible insight into disease biology, yet the richness of biology comes from the dynamic on and off switches that control the genome – gene regulation. the fulcrum product eng

Organization	Fulcrum Therapeutics
Employees	76
CEO	Mr. Alexander C. Sapir
Industry	Health Technology

Management People of Fulcrum Therapeutics

Name	Title
Mr. Alexander C. Sapir	CEO, President & Director
Mr. Alan A. Musso C.M.A., CPA	Chief Financial Officer
Mr. Curtis G. Oltmans J.D.	Senior VP, Chief Legal Officer & Corporate Secretary
Mr. Mel Hayes	Executive Vice President of Patient Experience
Dr. Bradley E. Bernstein M.D., Ph.D.	Founder
Dr. Michael R. Green	Founder
Dr. Rudolf Jaenisch M.D., Ph.D.	Founder
Dr. Tsun-Huei Lee M.D., Ph.D.	Founder
Dr. Danny Reinberg	Founder
Mr. Gregory Tourangeau	Controller & Principal Accounting Officer

Important FAQs about investing in Fulcrum Therapeutics from India :

What is Fulcrum Therapeutics share price today?

Fulcrum Therapeutics share price today stands at $4.55, Open: $4.70 ; Previous Close: $4.68 ; High: $4.76 ; Low: $4.35 ; 52 Week High: $13.70 ; 52 Week Low: $2.86. The stock opens at $4.70, after a previous close of $4.68. The stock reached a daily high of $4.76 and a low of $4.35, with a 52-week high of $13.70 and a 52-week low of $2.86.

Can Indians buy Fulcrum Therapeutics shares?

Yes, Indians can invest in the Fulcrum Therapeutics (FULC) from India.

With INDmoney, you can buy Fulcrum Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Fulcrum Therapeutics at zero transaction cost.

How can I buy Fulcrum Therapeutics shares from India?

It is very easy to buy Fulcrum Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Fulcrum Therapeutics be purchased?

Yes, you can buy fractional shares of Fulcrum Therapeutics with INDmoney app.

What are the documents required to start investing in Fulcrum Therapeutics stocks?

To start investing in Fulcrum Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.